News & Events :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Recent NewsView All News

Aug 26, 2024 8:00am EDT

Alzamend Neuro Issues Letter to Stockholders

Aug 19, 2024 8:00am EDT

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder

Latest Presentation View All Presentations

Corporate Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings